Corbus Pharmaceuticals Holdings, Inc. - CRBP

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 10, 2026 SCHEDULE 13G/A Octagon Capital Advisors LP 5.4% 955,000 View
Feb 10, 2026 SCHEDULE 13G/A Octagon Investments Master Fund LP 5.4% 955,000 View
Feb 10, 2026 SCHEDULE 13G/A Ting Jia 5.4% 955,000 View
Jan 16, 2026 SCHEDULE 13G Aberdeen Group plc 7.53% 1,321,750 View
Jan 16, 2026 SCHEDULE 13G abrdn Inc. 7.53% 1,321,750 View
Dec 15, 2025 SCHEDULE 13G/A Cormorant Asset Management, LP 13.36% 2,344,971 View
Dec 15, 2025 SCHEDULE 13G/A Chen Bihua 13.36% 2,344,971 View
Nov 14, 2025 SCHEDULE 13G/A Cormorant Asset Management, LP 12.82% 2,375,000 View
Nov 14, 2025 SCHEDULE 13G/A Bihua Chen 12.82% 2,375,000 View
Nov 12, 2025 SCHEDULE 13G Citadel Advisors LLC 4.7% 873,313 View
Nov 12, 2025 SCHEDULE 13G Citadel Advisors Holdings LP 4.7% 873,313 View
Nov 12, 2025 SCHEDULE 13G Citadel GP LLC 4.7% 873,313 View
Nov 12, 2025 SCHEDULE 13G Citadel Securities LLC 0.6% 107,297 View
Nov 12, 2025 SCHEDULE 13G Citadel Securities Group LP 0.6% 107,297 View
Nov 12, 2025 SCHEDULE 13G Citadel Securities GP LLC 0.6% 107,297 View
Nov 12, 2025 SCHEDULE 13G Kenneth Griffin 5.3% 980,610 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.